Endoscopic Intravariceal Injection Sclerotherapy with 5% Ethanolamine in 187 Acute Oesophageal Variceal Bleeding Patients

One hundred and eighty seven patients (161 males and 26 females) with endoscopically proven active variceal bleeding underwent endoscopic sclerotherapy by the intravariceal method (EST). All of the patients were cirrhotic and 37.4 percent (70/187) had associated underlying diseases. The patients...

Full description

Saved in:
Bibliographic Details
Main Authors: Sommai WILAIRATANA, Polrat WILAIRATANA
Other Authors: Chulalongkorn University
Format: Article
Published: 2018
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/22453
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
id th-mahidol.22453
record_format dspace
spelling th-mahidol.224532018-08-10T15:48:30Z Endoscopic Intravariceal Injection Sclerotherapy with 5% Ethanolamine in 187 Acute Oesophageal Variceal Bleeding Patients Sommai WILAIRATANA Polrat WILAIRATANA Chulalongkorn University Mahidol University Medicine One hundred and eighty seven patients (161 males and 26 females) with endoscopically proven active variceal bleeding underwent endoscopic sclerotherapy by the intravariceal method (EST). All of the patients were cirrhotic and 37.4 percent (70/187) had associated underlying diseases. The patients' status before EST, according to Child‐Turcotte's classification, were class A % 6.4%, class B = 49. 7%, and class C = 43% respectively. An intravariceal injection with 4 ml of ethanolamine oleate per varix through an Olympus fiberoptic scope was performed. Then sclerotherapy sessions required for each patients was different. Seventy four percent (138/187) required only one session. Neither a compression balloon nor sliding tube after injection were used. Bleeding was arrested in all cases after this method. The results revealed that recurrent bleeding developed in 17.6 percent of the patients (33/187) and occurred between one day (one case) to two years afer EST. Hemorrhagic gastritis (22/187) was the major cause of post sclerotherapy bleeding. Complications related with EST in this report occurred in two patients (1.06 percent). The first case had a low grade fever after treatment which spontaneously subsided on day three after EST without any specific medication. The other one had oesophageal perforation and died with severe post operative sepsis. Copyright © 1992, Wiley Blackwell. All rights reserved 2018-08-10T08:48:30Z 2018-08-10T08:48:30Z 1992-01-01 Article Digestive Endoscopy. Vol.4, No.3 (1992), 209-212 10.1111/j.1443-1661.1992.tb00081.x 14431661 09155635 2-s2.0-0026714589 https://repository.li.mahidol.ac.th/handle/123456789/22453 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0026714589&origin=inward
institution Mahidol University
building Mahidol University Library
continent Asia
country Thailand
Thailand
content_provider Mahidol University Library
collection Mahidol University Institutional Repository
topic Medicine
spellingShingle Medicine
Sommai WILAIRATANA
Polrat WILAIRATANA
Endoscopic Intravariceal Injection Sclerotherapy with 5% Ethanolamine in 187 Acute Oesophageal Variceal Bleeding Patients
description One hundred and eighty seven patients (161 males and 26 females) with endoscopically proven active variceal bleeding underwent endoscopic sclerotherapy by the intravariceal method (EST). All of the patients were cirrhotic and 37.4 percent (70/187) had associated underlying diseases. The patients' status before EST, according to Child‐Turcotte's classification, were class A % 6.4%, class B = 49. 7%, and class C = 43% respectively. An intravariceal injection with 4 ml of ethanolamine oleate per varix through an Olympus fiberoptic scope was performed. Then sclerotherapy sessions required for each patients was different. Seventy four percent (138/187) required only one session. Neither a compression balloon nor sliding tube after injection were used. Bleeding was arrested in all cases after this method. The results revealed that recurrent bleeding developed in 17.6 percent of the patients (33/187) and occurred between one day (one case) to two years afer EST. Hemorrhagic gastritis (22/187) was the major cause of post sclerotherapy bleeding. Complications related with EST in this report occurred in two patients (1.06 percent). The first case had a low grade fever after treatment which spontaneously subsided on day three after EST without any specific medication. The other one had oesophageal perforation and died with severe post operative sepsis. Copyright © 1992, Wiley Blackwell. All rights reserved
author2 Chulalongkorn University
author_facet Chulalongkorn University
Sommai WILAIRATANA
Polrat WILAIRATANA
format Article
author Sommai WILAIRATANA
Polrat WILAIRATANA
author_sort Sommai WILAIRATANA
title Endoscopic Intravariceal Injection Sclerotherapy with 5% Ethanolamine in 187 Acute Oesophageal Variceal Bleeding Patients
title_short Endoscopic Intravariceal Injection Sclerotherapy with 5% Ethanolamine in 187 Acute Oesophageal Variceal Bleeding Patients
title_full Endoscopic Intravariceal Injection Sclerotherapy with 5% Ethanolamine in 187 Acute Oesophageal Variceal Bleeding Patients
title_fullStr Endoscopic Intravariceal Injection Sclerotherapy with 5% Ethanolamine in 187 Acute Oesophageal Variceal Bleeding Patients
title_full_unstemmed Endoscopic Intravariceal Injection Sclerotherapy with 5% Ethanolamine in 187 Acute Oesophageal Variceal Bleeding Patients
title_sort endoscopic intravariceal injection sclerotherapy with 5% ethanolamine in 187 acute oesophageal variceal bleeding patients
publishDate 2018
url https://repository.li.mahidol.ac.th/handle/123456789/22453
_version_ 1763488943107473408